When starting a vaccine program, scientists generally have anecdotal understanding of the disease they're aiming to target. When COVID-19 surfaced over a year ago, there were so many unknowns about the fast-moving virus that scientists had to act quickly and rely on new methods and techniques just to even begin understanding the basics of the disease.